PapersPMID:36297036
Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“The intake of p-synephrine did not modify MFO (0.28 ± 0.08 vs. 0.26 ± 0.10 g/min, p = 0.449, d = 0.21, respectively) or Fatmax (44.6 ± 7.8 vs. 40.8 ± 8.6%, p = 0.096, d = 0.50, respectively) over the placebo condition.”
- Study
- crossover
- Dose studied
- 3 mg p-synephrine per kg body mass as synephrine HCl, single oral dose 60 min before the exercise test
- Population
- 18 healthy, recreationally active women, fasted, morning trials, one acute dose against a cellulose placebo in a randomised crossover; MFO taken from a ramp test on a cycle ergometer in 3-minute stages from 30% to 80% of VO2max
Study record
- Design
- crossover trial
- Species
- human
- Population
- healthy recreationally active women
- Participants
- 18
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 23
- Declined
- this platform holds no node for the endpoint